Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinde Placebo-Controlled Trial of Short-Chain Fatty Acid Supplementation on Graft Function, Inflammatory Profile, and Microbiome Composition After Primary Kidney Transplantation

NCT07024238 is registered in ClinicalTrials.gov with University Hospital, Martin as lead sponsor.

NCT NCT07024238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07024238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinde Placebo-Controlled Trial of Short-Chain Fatty Acid Supplementation on Graft Function, Inflammatory Profile, and Microbiome Composition After Primary Kidney Transplantation
Lead sponsor
University Hospital, Martin
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 4, 2025
Completion date
September 4, 2025
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse events, flow cytometry, gut microbiome, immune system, immunosuppressive agents, metabolic effects, metabolome, renal function